中文 | English
Return
Total: 136 , 1/14
Show Home Prev Next End page: GO
Author:(Wenhua XU)

1.Efficacy investigation of combination therapy with Alprostadil Lipo preparation and enoxaprian in acute coronary syndrome

Wenhua XU

Chinese Journal of Primary Medicine and Pharmacy 2010;17(23):3229-3230

2.Effect of chondroitin sulfate on the proliferation of HL60 cells and sensibility for chemotherapy

Wenhua XU

Basic & Clinical Medicine 2006;0(08):-

3.Equity Problem During Process of Mass Higher Education——Discussion on Tuition in Higher Education

Wenhua XU

Chinese Journal of Medical Education Research 2002;0(01):-

4.Investigation and analysis of male nurses' social support, job burnout and subjective well-being

Wenhua XU ; Liping WANG

Chinese Journal of Practical Nursing 2013;29(21):58-60

5.Correlation of adiponectin gene SNP+45 T/G polymorphism with coronary heart disease

Li XU ; Wenhua LING

Chinese Journal of Pathophysiology 1989;0(06):-

6.The telomerase activity and the homozygous deletions of p16 gene in liver metastases of colorectal carcinoma

Jinping MA ; Wenhua ZHAN ; Duorong XU

Chinese Journal of General Surgery 1997;0(06):-

7.Effects of Daphnetin on Activities of Protein Kinase A and Protein Kinase C in Vitro

Xueping XU ; Dianmo XIAO ; Wenhua ZHOU

Chinese Traditional and Herbal Drugs 1994;0(01):-

8.Clinical significance of CD4+ CD25+ CD127 low regulatory T cells expression in the peripheral blood of patients with acute cerebral infarction

Xiaofei CHEN ; Wenhua XU ; Mingshan REN

Acta Universitatis Medicinalis Anhui 2014;(5):633-636

9.Observation of Tanreqing Injections Combined with Azithromycin in the Treatment of Pediatric Bronchial Pneumonia

Wenhua YU ; Zhilan WU ; Yanfang XU

China Pharmacist 2014;(4):635-636

10.Advances in the management of carotid artery stenosis

Wenhua LIU ; Gelin XU ; Xinfeng LIU

International Journal of Cerebrovascular Diseases 2009;17(5):351-355

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 136 , 1/14 Show Home Prev Next End page: GO